和黄医药资产出售 国资缘何频现接盘中药领域?

21世纪经济报道
02 Jan

1月2日,上海医药发布公告表示,上海医药拟联合上海金浦健服股权投资管理有限公司指定主体共同收购和黄医药持有的上海和黄药业股权,其中上海医药拟以自有资金人民币9.95亿元(以最终国资备案价格为准)收购10%股权。  上海和黄药业是由上海医药全资子公司上海市药材有限公司与上海和黄医药投资(香港)有限公司合资设立,双方各持股50%。交易完成后,上海医药将合计持有上海和黄药业60%股权,对其实施并表。  ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10